Be in the know. 25 key reads for Thursday…

  1. Here’s What The “Fed’s Hiking Cycle” Market Backstest Shows (zerohedge)
  2. After a dazzling 2021 performance, here’s what contrarian investors are predicting for 2022, says Citi (marketwatch)
  3. Senate sends $768B defense policy bill to Biden The upper chamber voted 89-10 to pass the National Defense Authorization Act. (politico)
  4. Alibaba, Tencent and Chinese tech stocks are good values with policy conditions priced in, Lombard Odier says (scmp)
  5. China’s Bubble Bursting Has Wall Street Eyeing a 2022 Rally (bloomberg)
  6. China’s Bad Economic News Has a Bright Side for Investors (barrons)
  7. Art Cashin sees inflation peaking soon and other surprises for the market in 2022 (cnbc)
  8. Democrats are unlikely to pass Biden’s social spending plan this year — here’s what it means (cnbc)
  9. Omicron symptoms could seem like a cold (cnbc)
  10. Delta Air Lines forecasts pretax quarterly profit as travel demand, fares increase (cnbc)
  11. European Central Bank leaves interest rates unchanged, cuts bond buying further (cnbc)
  12. Intel to Invest $7 Billion in New Malaysian Plant to Help Solve Global Chip Shortages (barrons)
  13. Novartis to Spend Bulk of Roche Windfall on Buying Back Stock, Not M&A (barrons)
  14. 4 Healthcare Stocks That Wall Street Analysts Love (barrons)
  15. Boeing Loses Qantas Business to Airbus, but There Is Good News, Too (barrons)
  16. Why Jerome Powell Pivoted on Inflation (nytimes)
  17. Fed Doubles Taper, Signals Three 2022 Hikes in Inflation Pivot (bloomberg)
  18. Intel’s Mobileye Takes On Parisian Traffic in Test of Driverless Cars (bloomberg)
  19. ‘Sell Your Hedge and Move On’: Anxious Stocks Surge After Powell (bloomberg)
  20. Campbell Is Getting Warmer (wsj)
  21. AT&T Stock Jumps On Morgan Stanley Upgrade to ‘Overweight’ Amid Discovery Media Merger (yahoo)
  22. Opinion: The last time the S&P 500’s earnings yield lagged inflation this much, Harry Truman was president. (marketwatch)
  23. S. Healthcare Spending Rose Nearly 10% in 2020, Report Finds (wsj)
  24. China’s Covid-19 Lockdowns Starting to Sting (wsj)
  25. In a Bad Year for Biotech Stocks, Deals and Vaccines Were Winners (wsj)